Authors: Patten, M Koch, HP Sonntag, F Luderitz, B Meinertz, T

Citation: M. Patten et al., Antiarrhythmic drug therapy in the prophylaxis of symptomatic paroxysmal atrial fibrillation/flutter. Rationale and design of the SOPAT trial, Z KARDIOL, 88(3), 1999, pp. 185

Authors: Fetsch, T Burschel, G Breithardt, G Engberding, R Koch, HP Lukl, J Trappe, HJ Treese, N

Citation: T. Fetsch et al., Antiarrhythmic drug therapy after DC cardioversion of chronic atrial fibrillation - rationale and design of the PAFAC trial, Z KARDIOL, 88(3), 1999, pp. 195

Authors: Koch, HP Kavanaugh, MP Esslinger, CS Zerangue, N Humphrey, JM Amara, SG Chamberlin, AR Bridges, RJ

Citation: Hp. Koch et al., Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters, MOLEC PHARM, 56(6), 1999, pp. 1095-1104

Authors: Koch, HP Chamberlin, AR Bridges, RJ

Citation: Hp. Koch et al., Nontransportable inhibitors attenuate reversal of glutamate uptake in synaptosomes following a metabolic insult, MOLEC PHARM, 55(6), 1999, pp. 1044-1048